Thomas Mccourt, CEO, Director at Ironwood Pharma, holds 1.22M shares in Ironwood Pharma (Ticker: IRWD), holds 0.00 shares in Acceleron Pharma (Ticker: XLRN), holds ― shares in Pliant Therapeutics (Ticker: PLRX).

See the Hottest Stocks Based on Insider Trading >

Thomas Mccourt
Ironwood Pharma (IRWD)
CEO, Director

Ranked #18,662 out of 98,624 Corporate Insiders

Profitable Transactions

3 out of 4 Profitable Transactions

Average Return

+23.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

IRWD

0.00%

PLRX

A breakdown of Thomas Mccourt's holdings

See the Top Stocks by Insiders

Insider Roles

Ironwood Pharma
(IRWD)

CEO, Director

Pliant Therapeutics
(PLRX)

Director

Roles that Thomas Mccourt holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Ironwood Pharma
(IRWD)

Rating:Informative Sell

Date:Feb 14, 2024 - Today

Return:+49.30%

The most profitable trade made by Thomas Mccourt

See the Latest Stocks Traded by Insiders

Thomas Mccourt's Trading History

IRWD

Ironwood Pharma

Mar 12, 2024

CEO, Director

Uninformative Buy

―

$9.52M

XLRN

Acceleron Pharma

Nov 22, 2021

―

Uninformative Sell

―

$0.00

PLRX

Pliant Therapeutics

―

Director

―

List of latest transactions for each holding click on a transaction to see Thomas Mccourt's performance on stock

See All Insider Trading from Today

Thomas Mccourt insider profile FAQ

What is the percentage of profitable transactions made by Thomas Mccourt?

The percentage of profitable transactions made by Thomas Mccourt is 75%.

What is the average return per transaction made by Thomas Mccourt?

The average return per transaction made by Thomas Mccourt is 23.50%.

What stocks does Thomas Mccourt hold?

Thomas Mccourt holds: IRWD, XLRN, PLRX stocks.

What was Thomas Mccourt’s latest transaction?

Thomas Mccourt latest transaction was an Uninformative Buy of ―.

What was Thomas Mccourt's most profitable transaction?

Thomas Mccourt’s most profitable transaction was an Informative Sell of IRWD stock on February 14, 2024. The return on the trade was 49.30%.

What is Thomas Mccourt's role in Ironwood Pharma?

Thomas Mccourt's role in Ironwood Pharma is CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Thomas Mccourt Insider Profile

Thomas Mccourt Ironwood Pharma (IRWD)CEO, Director